Objective. To develop a set of disease activity measures for use in rheumatoid arthritis (RA)
clinical trials, as well as to recommend specific methods for assessing each outcome …

FOR many years disease activity in rheumatoid arthritis (RA) has been measured by an
enormous number of different variables as a single golden standard for measuring disease …

Objective Remission in rheumatoid arthritis (RA) is an increasingly attainable goal, but there
is no widely used definition of remission that is stringent but achievable and could be …

Objective Thresholds of minimal clinically important improvement (MCII) are needed to plan
and interpret clinical trials. We estimated MCIIs for the rheumatoid arthritis (RA) activity …

Objective To make recommendations on how to report disease activity in clinical trials of
rheumatoid arthritis (RA) endorsed by the European League Against Rheumatism (EULAR) …

There is no single 'gold standard'quantitative measure to assess and monitor the clinical
status in patients with rheumatoid arthritis (RA). Therefore, a variety of measures have been …

Objective Given the inconsistency of remission definitions in rheumatoid arthritis (RA) trials,
the goal of this American College of Rheumatology/European League Against Rheumatism …

Objective. Trials of rheumatoid arthritis (RA) treatments report the average response in
multiple outcome measures for treated patients. It is more clinically relevant to test whether …

There is no agreement as to which variable best mirrors disease activity in rheumatoid
arthritis (RA) and no studies have been performed on the validity of disease activity …

Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease with peripheral
synovitis as its main manifestation. The presentation of the disease and the course during …